Pliant Therapeutics, Inc. Profile Avatar - Palmy Investing

Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small…

Biotechnology
US, South San Francisco [HQ]

Balance Sheet

Loading...
End of PLRX's Analysis
CIK: 1746473 CUSIP: 729139105 ISIN: US7291391057 LEI: - UEI: -
Secondary Listings
PLRX has no secondary listings inside our databases.